Table 2 Clinical characteristics of participants with and without T2DM.
From: Cerebral blood flow, blood supply, and cognition in Type 2 Diabetes Mellitus
Participants with T2DM (n = 41) | Participants without T2DM (n = 39) | p-value | |
|---|---|---|---|
T2DM-related variables | |||
Duration of diabetes (years) | 9.8 ± 6.7 | — | |
Fasting Blood Glucose (mmol/l) | 7.5 ± 1.2 | 5.1 ± 0.3 | <0.001 |
HbA1c (%) | 6.7 ± 0.4 | 5.6 ± 0.4 | <0.001 |
HbA1c (mmol/mol) | 50.2 ± 4.9 | 38.0 ± 4.5 | <0.001 |
T2DM medication: | |||
None (%) | 12.2 | 100 | <0.001a |
Insulin (%) | 2.4 | — | |
Oral medication (%) | 75.6 | — | |
Insulin and oral medication (%) | 9.8 | — | |
Clinical variables | |||
BMI (kg/m2) | 29.2 ± 3.5 | 24.7 ± 2.8 | <0.001 |
SBP (mmHg) | 152 ± 18 | 131 ± 18 | <0.001 |
DBP (mmHg) | 83 ± 10 | 76 ± 13 | 0.013 |
Cardiovascular disease (%) | 20.5 | 13.5 | 0.4 |
Hypertension (%) | 95.1 | 38.5 | <0.001a |
Smoking status, never/former/current (%) | 23.7/71.1/5.3 | 23.7/55.3/21.1 | 0.114a |
Cognitive Score | |||
Cumulative cognition score | −0.60 ± 3.17 | 0.40 ± 2.36 | 0.117 |
Baseline MMSE total score | 28.6 ± 1.4 | 29.4 ± 0.8 | 0.006 |
